Sectors > > Esperion Therapeutics Inc

Esperion Therapeutics Inc(NASDAQ:ESPR)

Market Overview

48.8

1.09(2.28%)
Vol 343,318
10 Days Avg Vol 767200
3 Mo Avg Vol 56065500
52 Wk Lo/Hi $13.9 - $120.96
YTD Price Gain % 160.5%
10 Wks Moving Avg 102.25
200 Days Moving Avg 53.08
Liquidity Ratio 27,664.9
Market Cap 1,077,770,712

Related News View All

Summary

Esperion Therapeutics Inc is engaged in the research, development and commercialization of therapies for the treatment of patients with elevated levels of elevated levels of LDL-C.

Contact Information


Esperion Therapeutics Inc

Suite 150
3891 Ranchero Drive

Ann Arbor MI 48108

+1 734 887-390

None

http://www.esperion.com

Timothy M. Mayleben